跳至主要内容
临床试验/PACTR202209817035302
PACTR202209817035302尚未招募未知

Hysteroscopic Resection Of Cesarean Uterine Scar Defect Versus Levonorgestrel-releasing Intrauterine Device In Management of Patients With Postmenstrual Spotting :A Comparative study

suez canal university0 个研究点目标入组 48 人开始时间: 2022年9月22日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Patients aged between 20 and 45 years
  • - Women with a previous caesarean section (at least one previous cesarean delivery)
  • - postmenstrual spotting of at least two days and in whom ultrasound had shown a niche, they are considered to undergo a hysteroscopic niche resection or to receive
  • LNG-IUD (52 mg) insertion.

排除标准

  • -Fertility wish within 1 year
  • -Irregular menstrual cycle before the last cesarean delivery,
  • -Presence of an intrauterine device
  • -Coagulopathy
  • -The length of the uterine cavity less than 6 cm or more than 10 cm
  • -Current exogenous hormone treatment
  • -Other gynecological conditions that could cause prolonged bleeding such as leiomyoma, endometrial hyperplasia, ovarian endometriosis and pregnancy
  • -Patients had received hysteroscopic resection or LNG-IUD before intervention
  • -In hysteroscopy group, additional exclusion criteria are contraindication for general anesthesia and with residual myometrium thickness (RMT) less than 2.2 mm to prevent bladder injury and uterine perforation.

研究者

相似试验